SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission SK bioscience has submitted an IND application for a Phase 1/2 clinical trial of a new adjuvanted influenza vaccine, aiming to enhance protective efficacy for vulnerable populations.

SK bioscience Takes a Big Step with New Influenza Vaccine Candidate IND Submission #South_Korea #Seongnam #Influenza_vaccine #SK_bioscience #adjuvant_technology